Cystic fibrosis

British Medical Journal

Volumn 335, Issue 7632, 2007, Pages 1255-1259

  Davies, Jane C ^a,b   Alton, Eric W F W ^a,b   Bush, Andrew ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; ENZYME; LAXATIVE; PROKINETIC AGENT; TAURINE; URSODEOXYCHOLIC ACID;

AUTOSOMAL RECESSIVE INHERITANCE; BRONCHIECTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CYSTIC FIBROSIS; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; GENE MUTATION; GENITAL SYSTEM; GLUTEN FREE DIET; HUMAN; INCIDENCE; INTESTINE; IONTOPHORESIS; LUNG DISEASE; PANCREAS; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SCREENING; SWEAT TEST; THORAX RADIOGRAPHY;

COST OF ILLNESS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROLYTES; HUMANS; MASS SCREENING; SWEAT;

EID: 37749013600     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39391.713229.AD     Document Type: Review

References (23)

1. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007;29:522-6.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
3. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-15.
4. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
5. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006;173:475-82.
6. Rosenstein BJ, Cutting GR, for the Cystic fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statements. J Pediatr 1998;132:589-95.
7. Middleton PG, Geddes DM, Alton EWFW. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J 1994;7:2050-6.
8. Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007;6:57-65.
9. Wicks E. Cystic fibrosis. BMJ 2007;334:1270-1.
10. Jones AP, Wallis CE. Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2003;(3):CD001127.
11. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354:229-40.
12. Smyth A, Walters S. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2003;(3):CD001912.
13. Wood DM, Smyth AR. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev 2006;(1):CD004197.
14. Southern KW, Barker PM, Solis A. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2004;(2):CD002203.
15. Lands LC, Dezateux C, Crighton A. Oral non-steroidal antiinflammatory drug therapy for cystic fibrosis. Cochrane Database Syst Rev 1999;(2):CD001505.
16. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-55.
17. Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006;43(suppl 1):S49-55.
18. Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol 2002;111:1081-6.
19. Onady GM, Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2005;(3):CD004730.
20. Glasscoe CA, Quittner AL. Psychological interventions for cystic fibrosis. Cochrane Database Syst Rev 2003;(3):CD003148.
21. Davies JC, Alton EW. Airway gene therapy. Adv Genet 2005;54:291-314.
22. Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, et al. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr Pulmonal 2005;39:339-48.
23. Daviskas E, Anderson SD. Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med 2006;19:100-9.